Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Intelligence01:27

Intelligence

8.5K
The term "intelligence" is complex because it refers to both behavior and individuals, and its interpretation varies across cultures. European Americans tend to link intelligence with reasoning and cognitive skills, while in Kenya, it is tied to responsible participation in family and social life. In Uganda, intelligence is seen as the ability to know the right actions and carry them out effectively, while the Iatmul people of Papua New Guinea associate it with the capacity to remember...
8.5K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

399
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
399
Measures of Intelligence01:29

Measures of Intelligence

8.4K
Psychologists measure intelligence by using standardized tests that produce a score known as the intelligence quotient or IQ. To understand IQ tests, it's important to recognize the key principles behind their construction: validity, reliability, and standardization.
Validity refers to how well a test measures what it claims to measure. An intelligence test should accurately assess intelligence rather than another characteristic, like anxiety. Criterion validity is one way to evaluate this;...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of conventional and modified ultrafiltration on perioperative clinical outcome in neonates undergoing arterial switch operation.

Annals of pediatric cardiology·2026
Same author

Epidemiological and molecular analysis of the first outbreak caused by genotype C mumps virus in China.

Human vaccines & immunotherapeutics·2026
Same author

Quantifying the fidelity of in vitro human cell culture systems using a biomedical foundation model.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

From genes to trajectories: mapping genetic influences on Huntington's disease progression.

Bioinformatics (Oxford, England)·2026
Same author

Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience.

The Journal of clinical endocrinology and metabolism·2026
Same author

Multi-View Biomedical Foundation Models for Molecule-Target and Property Prediction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

5.3K

Artificial Intelligence for Clinical Trial Design.

Stefan Harrer1, Pratik Shah2, Bhavna Antony1

  • 1IBM Research, IBM Research Australia Lab, 3006 Melbourne, VIC, Australia.

Trends in Pharmacological Sciences
|July 22, 2019
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) can significantly improve drug development by optimizing clinical trial design. AI enhances patient selection and monitoring, aiming to reduce the high failure rates of clinical trials and lower development costs.

Keywords:
artificial intelligencecohort selectionmachine learningpatient monitoringpatient recruitmenttrial design

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.7K

Related Experiment Videos

Last Updated: Jan 21, 2026

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

5.3K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.7K

Area of Science:

  • Drug development
  • Clinical trial design
  • Artificial intelligence applications

Background:

  • Clinical trials represent a significant investment, costing $1.5-2.0 billion USD and spanning 10-15 years.
  • High clinical trial failure rates, with only 10% of compounds reaching the market, result in substantial financial losses ($800 million to $1.4 billion USD per trial).
  • Key factors contributing to trial failures include suboptimal patient cohort selection, inefficient recruiting, and inadequate patient monitoring.

Purpose of the Study:

  • To explore how artificial intelligence (AI) can be leveraged to enhance clinical trial design.
  • To identify specific AI applications that can address major causes of clinical trial failure.
  • To propose methods for increasing the success rate of drug development through AI-driven trial optimization.

Main Methods:

  • Review of recent advancements in artificial intelligence (AI) relevant to pharmaceutical research.
  • Analysis of AI's potential impact on patient cohort selection and recruitment strategies.
  • Assessment of AI-powered tools for real-time patient monitoring during clinical trials.

Main Results:

  • AI offers transformative potential for optimizing patient selection and recruitment, leading to more targeted and effective trials.
  • AI-driven monitoring systems can improve patient adherence and data quality, mitigating risks during trial execution.
  • Implementing AI in clinical trial design can substantially increase the likelihood of drug approval and reduce overall development costs.

Conclusions:

  • Artificial intelligence presents a powerful solution to the challenges facing modern clinical trials.
  • AI integration into trial design can significantly improve success rates and reduce the economic burden of drug development.
  • Future research should focus on the practical implementation and validation of AI tools in clinical trial settings.